Latest Regulatory Approvals News

Robex Resources shareholders have overwhelmingly approved a merger with Predictive Discovery, setting the stage for a combined entity targeting over 400,000 ounces of gold production annually by 2029.

Robex Resources shareholders have overwhelmingly approved a merger with Predictive Discovery, setting the stage for a leading gold producer in West Africa with combined annual output projected to exceed 400,000 ounces by 2029.

Charger Metals NL has announced a significant high-grade gold discovery at its Xmas Gold Discovery within the Mt Gordon tenement, part of the Lake Johnston Lithium and Gold Project. This breakthrough enhances the prospectivity of multiple undrilled targets and sets the stage for an expanded exploration campaign in 2026.

Memphasys Limited has completed a $579K shortfall placement, boosting total funds raised to over $1.12 million to support the commercial rollout of its Felix™ System following recent regulatory approvals.

Origin Energy backs a landmark US$1 billion equity raise for Kraken Technologies, valuing the company at US$8.65 billion and maintaining a significant stake as Kraken prepares to separate from Octopus Energy.

Aeris Resources has received critical development consent from NSW authorities for its Constellation Project, paving the way for near-term production growth. The project boasts a substantial ore reserve with promising copper, gold, and silver grades.

Li-FT Power has signed a definitive agreement to acquire Azimut Exploration's 50% interest in the Galinée lithium property, a crucial step enabling its planned takeover of Winsome Resources. This deal strengthens Li-FT's position in Quebec's lithium sector alongside Winsome's flagship Adina project.

Memphasys has secured CE Mark approval for its Felix™ sperm selection system, enabling full commercial rollout across Europe and activating multi-year contracts worth over A$1.3 million. This milestone signals the company’s transition into a revenue-scaling phase with global growth ambitions.

High Peak Royalties finalises the sale of its geothermal subsidiary Torrens Energy to Northstar Energy, gaining significant equity and royalty interests while advancing South Australia's clean energy ambitions.

Clarity Pharmaceuticals’ novel diagnostic agent Cu-SAR-bisPSMA has been selected for oral presentation at the prestigious European Association of Urology Congress 2026, following promising Phase II trial results demonstrating superior detection of prostate cancer recurrence.

Beacon Minerals has agreed to sell its Mt Dimer tenements to Forrestania Resources for A$50,000, marking a strategic move to focus on core assets and reduce costs.

Forrestania Resources has acquired key tenements at Mt Dimer from Beacon Minerals, significantly expanding its gold exploration footprint in Western Australia’s Southern Cross Domain. The move aligns with the company’s strategy to consolidate and explore highly prospective gold belts.